ALLMedicine™ Atopic Dermatitis Center

Jan 23rd, 2021 - Patient-Reported Outcomes Measurement Information System Global Health (PGH) was validated to assess health-related quality of life (HRQOL) in several diseases. Little is known about its measurement properties in adult atopic dermatitis (AD). Exam...

Jan 23rd, 2021 - Dupilumab Therapy for Alopecia Areata in Pediatric Patients with Concomitant Atopic Dermatitis.|2021|McKenzie PL,Castelo-Soccio L,|

Jan 23rd, 2021 - Atopic dermatitis (AD) is chronic, pruritic, inflammatory skin disease that affects a significant portion of the population in industrialized nations. For non-responders to conventional therapies, AD can significantly reduce sleep quality and qual...

Jan 23rd, 2021 - Immunoregulatory effects of IL-4/IL-13 and alterations of keratinocyte differentiation are important factors in the pathogenesis of atopic dermatitis (AD). This study investigated the role of IL-4/IL-13 in keratinocyte responses to changes in extr...

Jan 22nd, 2021 - Atopic dermatitis (AD) presents with the wide spectrum of clinical phenotypes within and between various populations. Recent study showed low frequency of filaggrin loss-of-function (FLG LOF) mutations in Croatian AD patients. At present, there ar...

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

Jan 23rd, 2021 - Patient-Reported Outcomes Measurement Information System Global Health (PGH) was validated to assess health-related quality of life (HRQOL) in several diseases. Little is known about its measurement properties in adult atopic dermatitis (AD). Exam...

Jan 23rd, 2021 - Dupilumab Therapy for Alopecia Areata in Pediatric Patients with Concomitant Atopic Dermatitis.|2021|McKenzie PL,Castelo-Soccio L,|

Jan 23rd, 2021 - Atopic dermatitis (AD) is chronic, pruritic, inflammatory skin disease that affects a significant portion of the population in industrialized nations. For non-responders to conventional therapies, AD can significantly reduce sleep quality and qual...

Jan 23rd, 2021 - Immunoregulatory effects of IL-4/IL-13 and alterations of keratinocyte differentiation are important factors in the pathogenesis of atopic dermatitis (AD). This study investigated the role of IL-4/IL-13 in keratinocyte responses to changes in extr...

Jan 22nd, 2021 - Atopic dermatitis (AD) presents with the wide spectrum of clinical phenotypes within and between various populations. Recent study showed low frequency of filaggrin loss-of-function (FLG LOF) mutations in Croatian AD patients. At present, there ar...

Jan 21st, 2021 - Atopic dermatitis (AD), or atopic eczema, is a chronic inflammatory skin disorder that commonly presents as pruritic, ill-defined, dry patches with excoriations. AD can affect any part of the body. Up to 14% of adults may be affected by AD, with s...

Jan 10th, 2021 - Patients with moderate to severe atopic dermatitis (AD) affecting between 10% and 50% of their body surface area (BSA) account for the majority of responders to baricitinib 2 mg, results from an analysis of phase 3 data showed. "This proposed clin...

Jan 7th, 2021 - Dupilumab treatment with concomitant topical corticosteroids provided rapid and sustained improvement in itch intensity and frequency in children aged 6-11 years with severe atopic dermatitis. Dr Gil Yosipovitch The findings come from a post hoc a...

Jan 4th, 2021 - A diagnosis of atopic dermatitis in individuals ages 15 years or older, compared with controls without atopic dermatitis, was nearly twice as likely to be associated with autoimmune disease, in a case control study derived from Swedish national he...

Dec 14th, 2020 - Dermatologists are more likely than are nondermatologists to follow practice guidelines when prescribing antihistamines to treat pruritus associated with atopic dermatitis (AD), according to an analysis of a national database.   The American Acade...